Further investigations were then conducted and here we give a detail report for the effects and working mechanisms of 1 on hormone-stimulated adipogenesis, and dexamethasone-induced insulin resistance and adipocyte dysfunction. Rosiglitazone, which is an insulin sensitizer working as agonist of peroxisome proliferator-activated receptor γ, was used as the drug control. Here, INS is linked to Insulin resistance.